Abatacept treatment for rheumatoid arthritis

por Schiff, Michael
Publicado 2011

Subcutaneous abatacept for the treatment of rheumatoid arthritis

por Schiff, Michael
Publicado 2013

Co-stimulation Therapy in Rheumatoid Arthritis: Today and Tomorrow

por Schiff, Michael
Publicado 2015

A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations

por Wells, Alvin F, Jodat, Nicole, Schiff, Michael
Publicado 2014

Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥1...

por Schiff, Michael H, Jaffe, Jonathan S, Freundlich, Bruce
Publicado 2014

Chronic Disease and Self-Injection: Ethnographic Investigations into the Patient Experience During Treatment

por Schiff, Michael, Saunderson, Shane, Mountian, Irina, Hartley, Paul
Publicado 2017

Brief Report: Estimating Disease Activity Using Multi‐Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or Adalimumab

por Fleischmann, Roy, Connolly, Sean E., Maldonado, Michael A., Schiff, Michael
Publicado 2016

Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis

por Degboé, Yannick, Schiff, Michael, Weinblatt, Michael, Fleischmann, Roy, Ahmad, Harris A., Constantin, Arnaud
Publicado 2020

Usability and Acceptability of the Abatacept Pre-Filled Autoinjector for the Subcutaneous Treatment of Rheumatoid Arthritis

por Schiff, Michael, Koo, Joe, Jin, Erik, Schiller, Eric, Day, Ashley, Stevens, Rebecca, Laskar, Christina
Publicado 2016

Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics

por Kremer, Joel M, Schiff, Michael, Muram, David, Zhong, Jinglin, Alam, Jahangir, Genovese, Mark C
Publicado 2018

From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devices

por Boeri, Marco, Szegvari, Boglarka, Hauber, Brett, Mange, Brennan, Mountian, Irina, Schiff, Michael, Maniadakis, Nikolaos
Publicado 2019

Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial...

por Fleischmann, Roy, Weinblatt, Michael, Ahmad, Harris, Maldonado, Michael A., Alemao, Evo, Ye, June, Schiff, Michael
Publicado 2019

Double-Blind Randomized Trials of Single-Tablet Ibuprofen/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers

por Laine, Loren, Kivitz, Alan J, Bello, Alfonso E, Grahn, Amy Y, Schiff, Michael H, Taha, Ali S
Publicado 2012

Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss pro...

por Mueller, Ruediger B, Kaegi, Toni, Haile, Sarah R, Schulze-Koops, Hendrik, Schiff, Michael, von Kempis, Johannes
Publicado 2018

A Novel Role for the TIR Domain in Association with Pathogen-Derived Elicitors

por Burch-Smith, Tessa M, Schiff, Michael, Caplan, Jeffrey L, Tsao, Jeffrey, Czymmek, Kirk, Dinesh-Kumar, Savithramma P
Publicado 2007

Integrated safety in tocilizumab clinical trials

por Schiff, Michael H, Kremer, Joel M, Jahreis, Angelika, Vernon, Emma, Isaacs, John D, van Vollenhoven, Ronald F
Publicado 2011

Correction: A Novel Role for the TIR Domain in Association with Pathogen-Derived Elicitors

por Burch-Smith, Tessa M, Schiff, Michael, Caplan, Jeffrey L, Tsao, Jeffrey, Czymmek, Kirk, Dinesh-Kumar, Savithramma P
Publicado 2016

Reductions in disease activity in the AMPLE trial: clinical response by baseline disease duration

por Schiff, Michael, Weinblatt, Michael E, Valente, Robert, Citera, Gustavo, Maldonado, Michael, Massarotti, Elena, Yazici, Yusuf, Fleischmann, Roy
Publicado 2016

Patient‐Reported Outcomes From a Two‐Year Head‐to‐Head Comparison of Subcutaneous Abatacept and Adalimumab for Rheumatoid Arthritis

por Fleischmann, Roy, Weinblatt, Michael E., Schiff, Michael, Khanna, Dinesh, Maldonado, Michael A., Nadkarni, Anagha, Furst, Daniel E.
Publicado 2016

Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort

por Heinimann, Katja, von Kempis, Johannes, Sauter, Rafael, Schiff, Michael, Sokka-Isler, Tuulikki, Schulze-Koops, Hendrik, Müller, Rüdiger
Publicado 2018